Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Greenberg

Showing results (861-870 of 871) with videos related to

Pageof 88
Sort By:
The Journal of Allergy and Clinical Immunology|April 2, 2013
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosisElizabeth P Sampaio, Amy P Hsu, Joseph Pechacek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
European Urology|December 5, 2021
Inherited TP53 Variants and Risk of Prostate CancerKara N Maxwell, Heather H Cheng, Jacquelyn Powers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI): Developing Career Pathways for Early-Stage Scholars From Racial and Ethnic Groups Underrepresented in HIV Science and MedicineAlan E Greenberg, Anthony Wutoh, Lisa Bowleg, et al.
European Urology|January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER StudyNoah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
Neuron|January 29, 2013
Using whole-exome sequencing to identify inherited causes of autismTimothy W Yu, Maria H Chahrour, Michael E Coulter, et al.
Pageof 88

Showing results (861-870 of 871) with videos related to

Sort By:
Pageof 88
The Journal of Allergy and Clinical Immunology|April 2, 2013
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosisElizabeth P Sampaio, Amy P Hsu, Joseph Pechacek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
European Urology|December 5, 2021
Inherited TP53 Variants and Risk of Prostate CancerKara N Maxwell, Heather H Cheng, Jacquelyn Powers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI): Developing Career Pathways for Early-Stage Scholars From Racial and Ethnic Groups Underrepresented in HIV Science and MedicineAlan E Greenberg, Anthony Wutoh, Lisa Bowleg, et al.
European Urology|January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER StudyNoah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
Neuron|January 29, 2013
Using whole-exome sequencing to identify inherited causes of autismTimothy W Yu, Maria H Chahrour, Michael E Coulter, et al.
Pageof 88